Abstracts tagged "questionnaires and rheumatoid arthritis (RA)"

Abstract Number: 2871 • 2013 ACR/ARHP Annual Meeting
Validation Of The FLARE Self-Report Questionnaire For Assessing FLARE Out Of The Clinical Visit In Rheumatoid Arthritis
Jacques Morel¹, Jean-Marie Berthelot², Arnaud L. Constantin³, Michel De Bandt⁴, Philippe Gaudin⁵, Olivier Vittecoq⁶, Jean Francis Maillefert⁷, Olivier Meyer⁸, Thao Pham⁹, Alain Saraux¹⁰, Elisabeth Solau Gervais¹¹, Elisabeth Spitz¹², Daniel Wendling¹³, Francis Guillemin¹⁴ and Bruno Fautrel¹⁵, ¹Department of Rheumatology, Hôpital Lapeyronie, Montpellier, France, ²Rheumatology Unit, Nantes University Hospital, Nantes, France, ³Rheumatology, Purpan University Hospital, Toulouse, France, ⁴Rhumatologie Et Médecine Interne, Centre hospitalier Universitaire de Fort de France, Fort de France, Martinique, ⁵Rheumatology Department, CHU Hôpital Sud, Grenoble Teaching Hospital, Echirolles, France, ⁶Rheumatology, Department of Rheumatology, Rouen University Hospital & Inserm 905, Institute for Biomedical Research, University of Rouen, Rouen, France, ⁷University Hospital, Department of Rheumatology, Dijon, France, ⁸Rheumatology, Bichat University Hospital, Paris, France, ⁹Rheumatology Department, Sainte Marguerite Hospital, Marseille, France, ¹⁰Rhumatologie, CHU de la Cavale Blanche, Brest Cedex, France, ¹¹Departement of Rheumatology, CHU de Poitiers, Poitiers, France, ¹²UFR Sciences Humaines et Arts, APEMAC-EA4360, Metz, France, ¹³Rheumatology, University Hospital, Besancon, France, ¹⁴CHU Nancy, Clinical Epidemiology and Evaluation, Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France, ¹⁵Paris 6 – Pierre et Marie Curie University; AP-HP, Rheumatology, Pitié-Salpêtrière Hospital, - GRC-UPMC 08 – EEMOIS, Paris, France
Background/Purpose: Defining flare in rheumatoid arthritis (RA) raises a complex issue related to the difference in perception or concept of flare between patients or health…
Abstract Number: 2297 • 2013 ACR/ARHP Annual Meeting
Evaluating Depression Questionnaires In German Rheumatoid Arthritis Patients – Preliminary Results From a Validation Study
Matthias Englbrecht¹, Rieke Alten², Martin Aringer³, Christoph G. Baerwald⁴, Harald Burkhardt⁵, Nancy Eby⁶, Gerhard Fliedner⁷, Bettina Gauger⁸, Ulf Henkemeier⁹, Michael Hofmann¹⁰, Stefan Kleinert¹¹, Christian Kneitz¹², Christoph Pohl¹³, Georg Schett¹, Marc Schmalzing¹⁴, Anne-Kathrin Tausche¹⁵, Hans Peter Tony¹⁶ and Joerg Wendler¹⁷, ¹Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ²Teaching Hospital of the Charité, University of Berlin, Berlin, Germany, ³Rheumatology, Medicine III, University Clinical Center Technical University of Dresden, Dresden, Germany, ⁴Rheumatology, University Hospital, Leipzig, Germany, ⁵CIRI /Div. of Rheumatology, Goethe-University, Frankfurt/Main, Germany, ⁶Biostatistics, AMS-Advanced Medical Services, Mannheim, Germany, ⁷Praxis Osnabrück, Germany, Germany, Osnabrück, Germany, ⁸Roche Pharma AG, Grenzach, Germany, ⁹University Hospital Frankfurt, Frankfurt, Germany, ¹⁰Chugai Pharma, Frankfurt, Germany, ¹¹Rheumatology/Clinical Immunology,, University Hospital Würzburg, Würzburg, Germany, ¹²Internal Medicine II, Hospital Südstadt, Rostock, Germany, ¹³Rheumatology,Clinical Immunolo, Schlosspark Klinik, Berlin, Germany, ¹⁴Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, Germany, ¹⁵Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany, ¹⁶Rheumatology/Immunology, University of Würzburg, Würzburg, Germany, ¹⁷Schwerpunktpraxis Rheumatologie, Erlangen, Germany
Background/Purpose: To date, only a few studies have discussed the prevalence of depression in RA patients in Germany and depression questionnaires have not been validated…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].